Altamira Therapeutics Ltd (CYTO)
1.47
-0.11
(-6.96%)
USD |
NASDAQ |
May 08, 16:00
1.51
+0.04
(+2.72%)
Pre-Market: 09:14
Altamira Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Kiniksa Pharmaceuticals Ltd | 60.70% |
Tiziana Life Sciences Ltd | -- |
Landos Biopharma Inc | -- |
Masimo Corp | 47.86% |
AbbVie Inc | 66.74% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -56.18% |
Return on Invested Capital | -199.8% |
Return on Net Operating Assets | -69.24% |